Dimensional Fund Advisors LP Regeneron Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 571,187 shares of REGN stock, worth $338 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

571,187

Previous 587,025 2.7%

Holding current value

$338 Million

Previous $418 Million 13.37%

% of portfolio

0.09%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$634.14 - $744.83 $10 Million - $11.8 Million	-15,838 Reduced 2.7%	571,187 $362 Million
Q4 2024 Feb 13, 2025	BUY	$701.85 - $1046.91 $11.9 Million - $17.8 Million	16,961 Added 2.98%	587,025 $418 Million
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $16.9 Million - $19.8 Million	-16,498 Reduced 2.81%	570,064 $599 Million
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $2.11 Million - $2.56 Million	-2,391 Reduced 0.41%	586,562 $616 Million
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $4.12 Million - $4.54 Million	-4,569 Reduced 0.77%	588,953 $567 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $20 Million - $22.7 Million	-25,744 Reduced 4.16%	593,522 $521 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $4.46 Million - $5.44 Million	6,442 Added 1.05%	619,266 $510 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $14.5 Million - $17.2 Million	-20,684 Reduced 3.26%	612,824 $440 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $734,929 - $893,127	-1,080 Reduced 0.17%	633,508 $521 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $11.2 Million - $12.1 Million	-15,819 Reduced 2.43%	634,588 $458 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $10.6 Million - $13.4 Million	18,501 Added 2.93%	650,407 $448 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $25.6 Million - $34.5 Million	46,757 Added 7.99%	631,906 $374 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $49.2 Million - $57.7 Million	82,651 Added 16.45%	585,149 $409 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $53.8 Million - $66.4 Million	98,968 Added 24.53%	502,498 $317 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $47.8 Million - $56.7 Million	83,276 Added 26.0%	403,530 $244 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $33.1 Million - $39.2 Million	70,107 Added 28.03%	320,254 $179 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $5.94 Million - $7.29 Million	13,304 Added 5.62%	250,147 $118 Million
Q4 2020 Feb 25, 2021	BUY	$478.3 - $607.98 $113 Million - $144 Million	236,843 New	236,843 $114 Million

Others Institutions Holding REGN

# of Institutions

1,469

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $63.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Regeneron Pharmaceuticals, Inc. Transaction History